[A hormonal drug melatonin in the treatment of cognitive function disorders in parkinsonism].
Pineal hormone melatonin, which is known to possess neuroptotector and nootrope activity, also produces a significant therapeutic effect with respect to various brain pathologies. The review of original and published data suggests that it is expedient to use melatonin in the treatment of cognitive disorders accompanying Parkinson's disease.
Arushanian
E B
EB
D003072:Cognition Disorders / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D003342:Corpus Striatum / Q000503:physiopathology; D003704:Dementia / Q000503:physiopathology / Q000523:psychology; D006801:Humans; D008550:Melatonin / Q000502:physiology / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D018697:Nootropic Agents / Q000627:therapeutic use*; D020734:Parkinsonian Disorders / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D010870:Pineal Gland / Q000503:physiopathology
D018696:Neuroprotective Agents; D018697:Nootropic Agents; D008550:Melatonin